PPARGC1A and metabolic disease: Given its pivotal role in the control of energy expenditure, it is not surprising that a dysfunctional AMPK/PGC-1α/Sirt1 signaling axis should be responsible for reduced muscle energy expenditure, as occurs in aging and in metabolic disorders, such as type 2 diabetes (T2D) [49].